logo-loader

Monto Minerals hits high grade tin at Governor Norman in Queensland

Published: 01:40 14 May 2014 EDT

au_qld_map_350_5372d1ed4c0a9

Monto Minerals (ASX:MOO) has completed the initial drilling program at the Governor Norman prospect within its Herberton Tin Project, Queensland.

Significant results returned included 4 metres at 1.2% tin from 46 metres, and the deeper drill holes to test extensions to mined mineralisation demonstrated continuity of alteration in areas not previously drilled.

Notably, this was the first exploration drilling undertaken at Governor Norman since the 1980’s.
 
The Governor Norman prospect comprises several historic high grade tin mines over a strike extent of 1.2 kilometres.

Compilation of historic drilling of 644 surface and underground holes at Governor Norman indicated that the structural zone hosting the workings is broadly mineralised at low grade.

The vast majority of the 644 drill holes at Governor Norman are shallow air track holes with only 22 reverse circulation or diamond holes drilled to a depth greater than 100 metres, representing just 3.4% of all holes drilled.

Results from historic drilling data indicate potential to define a low grade mineralised zone of significant tonnage along the Governor Norman trend.

Should an economic deposit be confirmed, the path to cash flow should be relatively simple, with the former Jumna processing plant located just 2 kilometres to the north.

The Governor Norman area has been historically worked by open pit and underground methods from 1905 until cessation of mining in 1987 due to a collapse in the nickel price.

Total combined historic production was 1,300 tons of tin concentrate at an estimated 1% tin.

Monto is currently assessing the results of the drilling program to determine further work at the regionally significant Governor Norman zone of mineralisation.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

51 minutes ago